Dopamine agonist therapy in Parkinson¿s disease: Spanish expert consensus on its use in different clinical situations D. Santos García; J. Pagonabarraga Mora; F. Escamilla Sevilla; P.J. García Ruiz; J. Infante Ceberio; J. Kulisevsky Bojarski; G. Linazasoro Cristóbal; M.R. Luquín Piudo; J.C. Martínez Castrillo; S. Jesús Maestre; L. Vela Desojo; F.J. Campos Lucas; F. Caballero Martínez; P. Mir;

Mortality rates for Parkinson¿s disease are increasing in Spain. An age-period-cohort and joinpoint analysis of mortality rates from 1981 to 2020 C. García-Muñoz; J.C. Hernández-Rodríguez; J.J. Pereyra-Rodriguez;

Beta-caryophyllene inhibits the permeability of the blood¿brain barrier in MPTP-induced parkinsonism A.R. Ramos-Molina; A.R. Tejeda-Martínez; J.M. Viveros-Paredes; V. Chaparro-Huerta; M.F. Urmeneta-Ortíz; L.J. Ramírez-Jirano; M.E. Flores-Soto;